21577 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being alphaMSH, alpha melanocyte stimulating hormone
Enhanced in Vivo Targeting of Site-Specific Drugs
#2COMPOUNDS WITH REDUCED RING SIZE FOR USE IN DIAGNOSING AND TREATING MELANOMA, INCLUDING METASTATIC MELANOMA AND METHODS RELATED TO SAME
#3Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#4Radiolabeled Alpha-Melanocyte Stimulating Hormone Hybrid Peptide for Melanoma Targeting
#5Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#6Fluorescent silica-based nanoparticles
#7Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting
#8Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#9Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#10Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#11Method for delivering alpha-melanocyte stimulating hormone mimetibody composition comprising propylene glycol for intranasal administration to the central nervous system
#12Agents and methods for visualizing analytes
#13Fluorescent silica-based nanoparticles
#14Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#15Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#16Intranasal administration of active agents to the central nervous system
#17Chelating agent conjugated α-MSH peptide derivatives, preparation method thereof and composition for diagnosis and treatment of melanoma comprising the same as an active ingredient
#18Intranasal Administration of Active Agents to the Central Nervous System
#19Melanocortin Metallopeptode Combinatorial Libraries and Applications
#20Intranasal administration of active agents to the central nervous system
#21Methods for making metallopeptides and metallopeptide libraries
#22Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting